Clinical Trials
7 trialsNCT06046131 2025-11-17
KP-CARAIBES
Centre Hospitalier Universitaire de la Guadeloupe
Phase NA Recruiting
NCT03035448 2023-10-12
Communication Strategies to Introduce Psychology Services
M.D. Anderson Cancer Center
Phase NA Completed
NCT02514252 2021-05-18
Sublingual Fentanyl for the Management of Breakthrough Pain
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT02523378 2020-12-21
Edmonton Symptom Assessment Scale: Self-Completion vs. Assisted-Completion
M.D. Anderson Cancer Center
Phase NA Completed
NCT02422329 2018-03-22
Changes in Patient Reported Constipation Among Advanced Cancer Patients After Receiving an Educational Intervention
M.D. Anderson Cancer Center
Phase NA Completed
NCT01782976 2018-01-19
Ph II Cilengitide Plus Bevacizumab for Recurrent Glioblastoma (GBM)
M.D. Anderson Cancer Center
Phase 2 Withdrawn
NCT01518140 2013-08-13
BiPAP-Vapotherm RCT
M.D. Anderson Cancer Center
Phase 2 Withdrawn